
    
      The study is mainly for patients with Crawford type I-V thoracoabdominal aortic aneurysms,
      and all subjects who passed the screening and signed the informed consent will be enrolled.
      Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be
      implanted with thoracoabdominal aortic stent system.

      Patients will be followed up at discharge, 1 month, 6 months, 12 months after the
      implantation.
    
  